Insider Transactions in Q4 2021 at Celldex Therapeutics, Inc. (CLDX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 23
2021
|
Samuel Bates Martin SVP AND CFO |
SELL
Open market or private sale
|
Direct |
9,500
-28.04%
|
$399,000
$42.0 P/Share
|
|
Dec 23
2021
|
Samuel Bates Martin SVP AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+9.85%
|
$35,000
$5.9 P/Share
|
|
Dec 08
2021
|
Margo Heath Chiozzi SVP OF REGULATORY AFFAIRS |
SELL
Open market or private sale
|
Direct |
600
-5.06%
|
$24,000
$40.0 P/Share
|
|
Dec 08
2021
|
Margo Heath Chiozzi SVP OF REGULATORY AFFAIRS |
BUY
Exercise of conversion of derivative security
|
Direct |
600
+4.82%
|
$1,200
$2.78 P/Share
|
|
Dec 08
2021
|
Elizabeth Crowley SR. VP & CPDO |
SELL
Open market or private sale
|
Direct |
4,000
-45.84%
|
$160,000
$40.0 P/Share
|
|
Dec 08
2021
|
Elizabeth Crowley SR. VP & CPDO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+31.43%
|
$36,000
$9.02 P/Share
|
|
Dec 08
2021
|
Sarah Cavanaugh SVP OF CORP AFFAIRS & ADMIN. |
SELL
Open market or private sale
|
Direct |
7,323
-94.72%
|
$292,920
$40.0 P/Share
|
|
Dec 08
2021
|
Sarah Cavanaugh SVP OF CORP AFFAIRS & ADMIN. |
BUY
Exercise of conversion of derivative security
|
Direct |
7,323
+43.23%
|
$65,907
$9.7 P/Share
|
|
Nov 15
2021
|
Samuel Bates Martin SVP AND CFO |
SELL
Open market or private sale
|
Direct |
9,500
-13.78%
|
$408,500
$43.09 P/Share
|
|
Nov 15
2021
|
Samuel Bates Martin SVP AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+9.2%
|
$35,000
$5.9 P/Share
|
|
Nov 12
2021
|
Diane C. Young SVP, CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,600
-68.5%
|
$193,200
$42.94 P/Share
|
|
Nov 12
2021
|
Diane C. Young SVP, CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,600
+40.65%
|
$46,000
$10.38 P/Share
|
|
Nov 01
2021
|
Margo Heath Chiozzi SVP OF REGULATORY AFFAIRS |
SELL
Open market or private sale
|
Direct |
600
-5.06%
|
$24,600
$41.71 P/Share
|
|
Nov 01
2021
|
Margo Heath Chiozzi SVP OF REGULATORY AFFAIRS |
BUY
Exercise of conversion of derivative security
|
Direct |
600
+4.82%
|
$1,200
$2.78 P/Share
|
|
Nov 01
2021
|
Elizabeth Crowley SR. VP & CPDO |
SELL
Open market or private sale
|
Direct |
4,317
-19.09%
|
$181,314
$42.95 P/Share
|
|
Nov 01
2021
|
Elizabeth Crowley SR. VP & CPDO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,555
+48.61%
|
$17,110
$2.78 P/Share
|
|
Nov 01
2021
|
Sarah Cavanaugh SVP OF CORP AFFAIRS & ADMIN. |
SELL
Open market or private sale
|
Direct |
7,323
-55.26%
|
$307,566
$42.93 P/Share
|
|
Nov 01
2021
|
Sarah Cavanaugh SVP OF CORP AFFAIRS & ADMIN. |
BUY
Exercise of conversion of derivative security
|
Direct |
5,956
+26.65%
|
$29,780
$5.9 P/Share
|